Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients

New Delhi, Jun 11: Anti-viral drug remdesivir and tocilizumab, an immunomodulator, are being considered for "restricted use" on severely ill COVID-19 patients on "emergency and compassionate grounds", according to revised clinical management guidelines to be released soon. The much-touted

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2YiHwig

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post